Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

CJC-1295 (DAC) | Research Peptide UK

CJC-1295 (DAC) is a synthetic 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH) carrying a Drug Affinity Complex (maleimidopropionic acid) linker that binds serum albumin. Also known as CJC-1295 with DAC. It is supplied as a lyophilised powder strictly as a reference compound for in-vitro laboratory and analytical research. Research context (literature reference only) Published preclinical literature has investigated CJC-1295 (DAC) in in-vitro and animal-model studies of GHRH-receptor binding in laboratory assays. These references are provided solely to contextualise the compound as a laboratory reference standard and do not describe, and must not be interpreted as, any effect, benefit or outcome in humans. Specifications Synonyms: CJC-1295 with DAC CAS Number: 863288-34-0 Molecular Formula: C165H271N47O46 Molecular Weight: 3647.0 Da Appearance: White to off-white lyophilised powder Purity: ≥98% (HPLC) Format: Lyophilised powder Vial Size: 3ml Solubility: Soluble in bac

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

CJC-1295 (DAC) is a synthetic 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH) carrying a Drug Affinity Complex (maleimidopropionic acid) linker that binds serum albumin. Also known as CJC-1295 with DAC. It is supplied as a lyophilised powder strictly as a reference compound for in-vitro laboratory and analytical research.

Research context (literature reference only)

Published preclinical literature has investigated CJC-1295 (DAC) in in-vitro and animal-model studies of GHRH-receptor binding in laboratory assays. These references are provided solely to contextualise the compound as a laboratory reference standard and do not describe, and must not be interpreted as, any effect, benefit or outcome in humans.

Specifications

Synonyms: CJC-1295 with DAC CAS Number: 863288-34-0 Molecular Formula: C165H271N47O46 Molecular Weight: 3647.0 Da Appearance: White to off-white lyophilised powder Purity: ≥98% (HPLC) Format: Lyophilised powder Vial Size: 3ml Solubility: Soluble in bacteriostatic water Storage:

➝ Before reconstitution: Store lyophilised at −20 °C for long-term preservation. ➝ After reconstitution: Store at 2–8 °C.

Laboratory handling & storage

Store lyophilised at −20 °C. After reconstitution in bacteriostatic water, store at 2–8 °C. Reconstitution and handling information is provided for laboratory reference only and is not administration guidance.

Regulatory status

This product has no marketing authorisation from the MHRA, EMA, FDA or any other regulatory body for human or veterinary medicinal use. It is not a medicine, food, supplement or cosmetic.

Frequently asked questions

What is the CAS number of CJC-1295 (DAC)? The CAS number for CJC-1295 (DAC) is 863288-34-0.

What purity is CJC-1295 (DAC) supplied at? CJC-1295 (DAC) is supplied at ≥98% (HPLC), independently HPLC-verified. A Certificate of Analysis for each batch is published on our Lab Tests page.

Is a Certificate of Analysis available for CJC-1295 (DAC)? Yes – every batch of CJC-1295 (DAC) is third-party tested and the COA is available on our Lab Tests page.

How is CJC-1295 (DAC) stored and shipped? CJC-1295 (DAC) ships from the UK. Store as noted in the specifications; reconstitution information (where applicable) is provided as a laboratory handling reference only, using bacteriostatic water.

What is the molecular weight of CJC-1295 (DAC)? The molecular weight of CJC-1295 (DAC) is 3647.0 Da.

FOR LABORATORY RESEARCH USE ONLY – NOT FOR HUMAN OR VETERINARY USE. Not for human or animal consumption, in-vivo use, or any clinical, diagnostic, food, cosmetic or therapeutic application. No MHRA, EMA or FDA marketing authorisation. By purchasing you confirm you are a qualified researcher (18+/21+ where required) and accept the Research Use Terms.

Connected topics

Follow this recovery question